Entity

Time filter

Source Type

NEW HAVEN, CT, United States

Patent
Achillion Pharmaceuticals, Inc. | Date: 2015-07-20

The disclosure includes novel processes for producing Sovaprevir comprising adding compound E to F-1 to provide Sovaprevir. The disclosure further includes intermediates useful for producing Sovaprevir. The disclosure also include a novel crystalline form of Sovaprevir, Form F, and a method for preparing spray-dried amorphous Sovaprevir from crystalline Form F.


Patent
Achillion Pharmaceuticals, Inc. | Date: 2015-12-04

The invention provides pharmaceutical compositions comprising a compound of formula or a pharmaceutically acceptable salt or hydrate thereof. The compounds disclosed herein are potent and/or selective inhibitors of viral replication, particularly Hepatitis C virus replication, and the invention provides methods for treating Hepatitis C infections.


Patent
Achillion Pharmaceuticals, Inc. | Date: 2015-02-25

Compounds, methods of use, and processes for making inhibitors of complement factor D comprising Formula I, or a pharmaceutically acceptable salt or composition thereof, wherein R


Patent
Achillion Pharmaceuticals, Inc. | Date: 2015-02-25

Compounds, methods of use, and processes for making inhibitors of complement factor D comprising Formula I, or a pharmaceutically acceptable salt or composition thereof, wherein R


Patent
Achillion Pharmaceuticals, Inc. | Date: 2015-02-25

Compounds, methods of use, and processes for making inhibitors of complement factor D comprising Formula I, or a pharmaceutically acceptable salt or composition thereof, wherein R

Discover hidden collaborations